MINI FUTURE SHORT - BRISTOL-MYERS SQUIBB | Market Closed - Börse Stuttgart 03:44:56 2024-07-10 pm EDT | ||
| 3.49 EUR | -1.13% |
|
| Current month | -0.85% | ||
| 1 month | +2.05% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
| Date | Price | Change |
|---|---|---|
| 24-07-10 | 3.49 | -1.13% |
| 24-07-09 | 3.53 | -1.67% |
| 24-07-08 | 3.59 | -0.83% |
| 24-07-05 | 3.62 | +1.12% |
| 24-07-04 | 3.58 | -1.10% |
Delayed Quote Börse Stuttgart
Last update July 10, 2024 at 03:44 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Morgan Stanley |
| WKN | MB3LJ3 |
| ISIN | DE000MB3LJ35 |
| Date issued | 2023-02-13 |
| Strike | 78.78 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.92 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.65 € |
|---|---|
| Lowest since issue | 0.74 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.12
USD
Average target price
53.1
USD
Spread / Average Target
+29.14%
- Stock Market
- Certificates
- Certificat
